PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations

In this study, PCM and TAT co-modified liposome was developed as a novel drug carrier for myocardium delivery with evaluation of its in vitro and in vivo properties. Liposomes containing fluorescent probe coumarin-6 were prepared by thin-film hydration. The PCM ligands specifically bind to the PCM r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Huang, Hua, Zhang, Liangke, Bai, Yan, Chen, Huali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241121/
https://www.ncbi.nlm.nih.gov/pubmed/28165817
http://dx.doi.org/10.1080/10717544.2016.1253121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241121/
https://www.ncbi.nlm.nih.gov/pubmed/28165817
http://dx.doi.org/10.1080/10717544.2016.1253121

Ejemplares similares